Format
Sort by
Items per page

Send to

Choose Destination

Best matches for malignant neoplasm of prostate AND prostate specific antigen measurement AND prostate-specific antigen:

Search results

Items: 1 to 20 of 919

1.

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up.

Ha JY, Shin TJ, Jung W, Kim BH, Park CH, Kim CI.

Investig Clin Urol. 2017 May;58(3):164-170. doi: 10.4111/icu.2017.58.3.164. Epub 2017 Apr 13.

2.

Comparison of semi-automated and manual methods to measure the volume of prostate cancer on magnetic resonance imaging.

Marin L, Ezziane M, Comperat E, Mozer P, Cancel-Tassin G, Coté JF, Racoceanu D, Boudghene F, Lucidarme O, Cussenot O, Renard Penna R.

Diagn Interv Imaging. 2017 May;98(5):423-428. doi: 10.1016/j.diii.2017.02.004. Epub 2017 Mar 15.

PMID:
28330587
3.

A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.

van Die MD, Williams SG, Emery J, Bone KM, Taylor JM, Lusk E, Pirotta MV.

Prostate. 2017 May;77(7):765-775. doi: 10.1002/pros.23317. Epub 2017 Feb 9.

PMID:
28181675
4.

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group.

Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20.

PMID:
28007457
5.

Retzius Space Preservation Technique for Robotic-Assisted Laparoscopic Radical Prostatectomy in a Kidney Transplant Patient: First Case in Thailand and Our First Experience.

Jenjitranant P, Sangkum P, Sirisreetreerux P, Viseshsindh W, Patcharatrakul S, Kongcharoensombat W.

Transplant Proc. 2016 Nov;48(9):3130-3133. doi: 10.1016/j.transproceed.2016.03.035.

PMID:
27932164
6.

Is There Use for FDG-PET in Prostate Cancer?

Jadvar H.

Semin Nucl Med. 2016 Nov;46(6):502-506. doi: 10.1053/j.semnuclmed.2016.07.004. Epub 2016 Sep 3. Review.

PMID:
27825430
7.

Prognostic value of endocan in prostate cancer: clinicopathologic association between serum endocan levels and biochemical recurrence after radical prostatectomy.

Arslan B, Onuk Ö, Hazar İ, Aydın M, Çilesiz NC, Eroglu A, Nuhoglu B.

Tumori. 2017 Mar 24;103(2):204-208. doi: 10.5301/tj.5000535. Epub 2016 Jul 25.

PMID:
27470607
8.

Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Huang J, Mondul AM, Weinstein SJ, Koutros S, Derkach A, Karoly E, Sampson JN, Moore SC, Berndt SI, Albanes D.

Br J Cancer. 2016 Oct 25;115(9):1087-1095. doi: 10.1038/bjc.2016.305. Epub 2016 Sep 27.

9.

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.

Musunuru HB, Yamamoto T, Klotz L, Ghanem G, Mamedov A, Sethukavalan P, Jethava V, Jain S, Zhang L, Vesprini D, Loblaw A.

J Urol. 2016 Dec;196(6):1651-1658. doi: 10.1016/j.juro.2016.06.102. Epub 2016 Aug 26.

PMID:
27569437
10.

External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.

Poyet C, Wettstein MS, Lundon DJ, Bhindi B, Kulkarni GS, Saba K, Sulser T, Vickers AJ, Hermanns T.

J Urol. 2016 Nov;196(5):1402-1407. doi: 10.1016/j.juro.2016.05.081. Epub 2016 May 14.

PMID:
27188476
11.

EPCA2.22: A Silver Lining for Early Diagnosis of Prostate Cancer.

Pourmand G, Safavi M, Ahmadi A, Houdeh E, Noori M, Mashhadi R, Alizadeh F, Salimi E, Heydari F, Mehrsai A, Pourmand N.

Urol J. 2016 Oct 10;13(5):2845-2848.

12.

May ultrasound probe size influence pain perception of needle piercing during transrectal prostate biopsy? A prospective evaluation.

Fabiani A, Servi L, Filosa A, Fioretti F, Maurelli V, Tombolini F, Tallè M, Mammana G.

Arch Ital Urol Androl. 2016 Oct 5;88(3):223-227. doi: 10.4081/aiua.2016.3.223.

13.

Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.

Kobayashi M, Nukui A, Kamai T.

Int J Clin Oncol. 2017 Feb;22(1):174-180. doi: 10.1007/s10147-016-1038-1. Epub 2016 Sep 8.

PMID:
27631094
14.

The utility of urine-circulating miRNAs for detection of prostate cancer.

Stuopelyte K, Daniunaite K, Bakavicius A, Lazutka JR, Jankevicius F, Jarmalaite S.

Br J Cancer. 2016 Sep 6;115(6):707-15. doi: 10.1038/bjc.2016.233. Epub 2016 Aug 4.

PMID:
27490805
15.

The role of PSA in detection and management of prostate cancer.

Kirby R.

Practitioner. 2016 Apr;260(1792):17-21, 3. Review.

PMID:
27337755
16.

Effect of ejaculation on Serum Prostate-Specific Antigen concentration.

Tarhan F, Demir K, Orcun A, Madenci OC.

Int Braz J Urol. 2016 May-Jun;42(3):472-8. doi: 10.1590/S1677-5538.IBJU.2015.0116.

17.

"Total reconstruction" of the urethrovesical anastomosis contributes to early urinary continence in laparoscopic radical prostatectomy.

Liao X, Qiao P, Tan Z, Shi H, Xing N.

Int Braz J Urol. 2016 Mar-Apr;42(2):215-22. doi: 10.1590/S1677-5538.IBJU.2014.0666.

18.

[Efficacy of periprostatic nerve block anesthesia for pain control in transrectal ultrasound- guided systematic prostate biopsy].

Xie Y, Zhou FJ, Li YH, Jiang LJ, Wu ZM, Qin ZK, Han H, Liu ZW.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 May;36(5):701-4. Chinese.

PMID:
27222189
19.

The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).

Qi WX, Zhang Q, Li P, Zhang XM, Zhang GY, Wu B, Lu JJ, Jiang GL, Fu S.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1361-7. doi: 10.1007/s00432-016-2142-3. Epub 2016 Mar 23.

PMID:
27008005
20.

Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.

Alinezhad S, Väänänen RM, Ochoa NT, Vertosick EA, Bjartell A, Boström PJ, Taimen P, Pettersson K.

BMC Urol. 2016 Feb 29;16:10. doi: 10.1186/s12894-016-0128-8.

Supplemental Content

Loading ...
Support Center